Patents by Inventor Fu Xinping

Fu Xinping has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mutant Herpes Simplex Virus-2 for cancer therapy
    Patent number: 8986672
    Abstract: The present invention is directed to the composition and use of a modified Herpes Simplex Virus Type 2 (HSV-2) as a medicament in the treatment of cancer. The modified HSV-2 has fusogenic activity, and comprises a modified/mutated ICP 10 polynucleotide encoding a polypeptide having ribonucleotide reductase activity and lacking protein kinase activity.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: March 24, 2015
    Assignee: The University Of Houston
    Inventors: Xiaoliu Zhang, Fu Xinping
  • Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy
    Publication number: 20090215147
    Abstract: The present invention is directed to the composition and use of a modified Herpes Simplex Virus Type 2 (HSV-2) as a medicament in the treatment of cancer. The modified HSV-2 has fusogenic activity, and comprises a modified/mutated ICP10 polynucleotide encoding a polypeptide having ribonucleotide reductase activity and lacking protein kinase activity.
    Type: Application
    Filed: June 23, 2006
    Publication date: August 27, 2009
    Applicant: BAYLOR COLLEGE OF MEDICINE
    Inventors: Xiaoliu Zhang, Fu Xinping